Work

PEG‐IFN‐α‐2b therapy in BCR‐ABL–negative myeloproliferative disorders

Year: 2007

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.23018

Authors: Elias Jabbour, Hagop Kantarjian, Jorge Cortes, Deborah Thomas, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Stefan Faderl, Mary Ann Richie, Miloslav Beran, Francis Giles, Srdan Verstovsek

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1567165257

FWCI: 2.78

Cites: 23

Cited by: 112

Related to: 10